Doctor profile · Federal record
Dr. Gary Feldman, MD
Rheumatology Physician (CMS: Rheumatology) · Los Angeles, CA
- NPI 1841220373
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 47 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5230 Pacific Concourse Dr, Suite 100
Los Angeles, CA 900456200
(310) 297-9221
fax (310) 297-9222
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- California #G43953
- Medicaid
- CA #00G439530
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1841220373. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
57,049
Distinct HCPCS
10
Medicare allowed
$1,243,121
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 18,400 | 32 | $13 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 15,390 | 21 | $9 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10,800 | 27 | $41 | |
J0897 |
Injection, denosumab, 1 mg | 10,620 | 147 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 475 | 191 | $137 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 340 | 77 | $152 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 295 | 156 | $82 | |
36415 |
Insertion of needle into vein for collection of blood sample | 195 | 115 | $7 | |
96372 |
Injection of drug or substance under skin or into muscle | 142 | 24 | $16 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 118 | 92 | $98 |
In context: peer comparison
Among 20 peers in Los Angeles Rheumatology Physician, average services per provider: 599. This provider delivers 95× the peer median.Open Payments
Industry payments received
All-time total
$899
Transactions
18
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 4 | $376.94 | |
| Janssen Biotech, INC. | 2 | $155.37 | |
| Novartis Pharmaceuticals Corporation | 6 | $133.19 | |
| Ucb, INC. | 1 | $120.00 | |
| Abbvie INC. | 5 | $113.49 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
686
Patients
172
Total drug cost
$21,750
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 142 | 47 | $5,173 |
| Tramadol Hcl | Generic | 73 | 13 | $1,269 |
| Celecoxib | Generic | 57 | 21 | $3,689 |
| Prednisone | Generic | 54 | 19 | $573 |
| Diclofenac Sodium | Generic | 50 | 23 | $1,644 |
| Leflunomide | Generic | 46 | 15 | $3,254 |
| Allopurinol | Generic | 35 | 12 | $583 |
| Gabapentin | Generic | 34 | 0 | $566 |
| Meloxicam | Generic | 33 | 11 | $221 |
| Pregabalin | Generic | 32 | 0 | $1,707 |
Frequently asked questions
What is Dr. Gary Feldman's medical specialty?
Dr. Gary Feldman practices Rheumatology Physician in Los Angeles, CA.
Where does Dr. Gary Feldman practice?
Dr. Gary Feldman practices at 5230 Pacific Concourse Dr, Los Angeles, CA 900456200. Office phone: 3102979221.
What is Dr. Gary Feldman's NPI?
Dr. Gary Feldman's National Provider Identifier (NPI) is 1841220373, issued by NPPES.
Does Dr. Gary Feldman accept Medicare assignment?
Yes. Dr. Gary Feldman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gary Feldman commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.